MDMXF (Medmix AG) Moat Score: 0/10 (As of Jul. 12, 2026)


MDMXF Medmix AG MDMXF
61 GF Score
Price $17.40
GF Value $26.13
! 7 Warning Signs
View Full Analysis

What is Medmix AG Moat Score?

Medmix AG has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Medmix AG has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Medmix AG might have No Moat - No discernible moat.

Medmix AG  (OTCPK:MDMXF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Medmix AG Moat Score Related Terms

MDMXF
61GF Score
Medmix AG MDMXF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medmix AG (MDMXF) Overvalued in 2026?

Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued. The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.

Key valuation signals for MDMXF:

  • Moat Score: 0
  • GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medmix AG Business Description

Other Exchanges MEDXz:UKMEDX:Switzerland
Address Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score

Get the complete analysis for MDMXF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.40
Price
$26.13
GF Value